Skip to main content
Minesh Mehta, MD, Radiation Oncology, Miami, FL, Baptist Hospital of Miami

MineshPMehtaMDFASTRO

Radiation Oncology • Miami, FL

Central Nervous System Cancer, Thoracic Cancer

Professor and Chair, Radiation Oncology, School of Medicine, Florida International University

Request Appointment

Overview of Dr. Mehta

Dr. Minesh Mehta is a radiation oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami and South Miami Hospital. He received his medical degree from University of Zambia, School of Med and has been in practice 36 years. Dr. Mehta accepts several types of health insurance, listed below. He is one of 23 doctors at Baptist Hospital of Miami and one of 9 doctors at South Miami Hospital who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1984 - 1988
  • University of Zambia, School of Med
    University of Zambia, School of MedClass of 1981

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2015 - 2026
  • MD State Medical License
    MD State Medical License 2012 - 2025
  • CA State Medical License
    CA State Medical License 2011 - 2024
  • OH State Medical License
    OH State Medical License 2010 - 2024
  • IL State Medical License
    IL State Medical License 1985 - 2017
  • WI State Medical License
    WI State Medical License 1987 - 2017
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2010, 2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2013
  • Top Doctors:Baltimore Area Castle Connolly, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes  
    Mark R Gilbert, Kevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Terri S Armstrong, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, David G Brachman, Merid..., Neurosurgery
  • Multi-Institutional External Validation of a Novel Glioblastoma Prognostic Nomogram Incorporating MGMT Methylation  
    Shahed N Badiyan, Minesh P Mehta, Yuan James Rao, Liam T Kane, Jason K Molitoris, Jiayi Huang, Journal of Neuro-Oncology

Press Mentions

  • Miami Cancer Institute Hosts Particle Beam Radiotherapy Experts from Across the Globe
    Miami Cancer Institute Hosts Particle Beam Radiotherapy Experts from Across the GlobeJuly 15th, 2022
  • Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment Survival
    Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment SurvivalJune 2nd, 2022
  • Study by Miami Cancer Institute Physician Researchers Promises to Change Way Metastatic Brain Cancer Is Treated
    Study by Miami Cancer Institute Physician Researchers Promises to Change Way Metastatic Brain Cancer Is TreatedMarch 24th, 2022
  • Join now to see all

Grant Support

  • Nabtc (Ucsf Project Leader) U Of WisconsinNational Cancer Institute1998–2008
  • Phase II Trial Of EMD 121974 For Recurrent GlioblastomaNational Center For Research Resources2007
  • Phase II Study Of Xrt + Low-Dose Temozolomide Followed By Temozolomide + CPT-11National Center For Research Resources2006–2007
  • Phase I/II Study Of OSI-774 And CCI-779 In Recurrent Malignant GliomaNational Center For Research Resources2006–2007
  • Phase I/II Trial Of CPT-11 And Temozolomide In Recurrent Malignant GliomaNational Center For Research Resources2004–2006
  • Phase I/II Trial Of R115777 In Patients With Recurrent Malignant GliomaNational Center For Research Resources2004–2005
  • Improving Cancer Outcome--Adaptive Helical TomotherapyNational Cancer Institute2001–2005
  • Phase I/II ZD1839 In Astrocytoma Or Glioblastoma And MeningiomaNational Center For Research Resources2004
  • Phase I/II OSI-774 In Recurrent Malignant Gliomas And Malignant Gliomas Post XrtNational Center For Research Resources2004
  • Phase I Study Of Zd 1839 And Temozolomide For The Treatment Of GliomasNational Center For Research Resources2004
  • Tomotherapy Based On Functional MRINational Cancer Institute2001–2002
  • Tomotherapy Based Dose PER Fraction Escalation In NsclcNational Cancer Institute2001–2002
  • Phase II Trial Of Thymidine &Carboplatin For Recurrent Malignant GLINational Center For Research Resources1999–2002
  • Phase Ib/Ii Trial Of PC 0120as Radiosensitizer In Metastatic Brain CancerNational Center For Research Resources1998–2002
  • Trial Of Irinotecan In PTS W Recurrent Malignant GliomaNational Center For Research Resources2000
  • Gadolinium Texaphyrin (Pci-0120) Radiation Sensitizer In Whole Brain Radiation THNational Center For Research Resources2000
  • Therapeutic Studies Of Primary CNS MalignanciesNational Cancer Institute1994–1997

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS California PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    First Health PPO
    Great West PPO
    HealthLink PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Minesh Mehta, Dr. Minesh Mehta, MD, Dr. M Mehta, Dr. Minesh P Mehta